Posted on 28 January 2014
The £85,000 Enterprise Fellowship will allow Professor Jon Timmis, from York’s Department of Electronics, to commercialise the software and to develop a new company into a viable business over the next 12 months.
Together with Dr Mark Coles, from York’s Centre for Immunology and Infection, Professor Timmis has created new computer modelling software which can help drug developers predict the effects of new drugs on autoimmune diseases, such as Rheumatoid Arthritis, Type 1 Diabetes, and Multiple Sclerosis.
Autoimmune conditions, where the immune system attacks its own tissues, affect 10 per cent of the UK’s adult population and are a leading cause of death and disability.
As well as funding, Professor Timmis will also receive one-to-one mentoring from some of the UK’s top technology entrepreneurs as part of the Academy’s Enterprise Hub.
Professor Timmis, who is also a Royal Society-Wolfson Research Merit Award Holder, said: “I first became interested in commercialisation of my research after discussions with various pharmaceutical companies and collaborators concerning my work and the avenues by which it might be exploited.
“It became clear there was significant interest in the potential for my research and expertise to make a significant impact at various stages of the drug discovery pipeline. I am now enthused with the prospect of commercialisation and consider it a natural extension to the academic research process, which can ensure the work achieves its intended aim.”
The new modelling software, which was developed with support from the University’s Centre for Chronic Diseases and Disorders (C2D2), is capable of integrating more data types than current systems and has two key areas of application in the field of immune and inflammatory diseases – drug development and personalised medicine.
Professor Timmis is one of eight researchers from UK universities to receive Royal Academy of Engineering funding to be spent exclusively on developing a spin-out business based on their technological innovations.
Arnoud Jullens, Head of Enterprise at the Royal Academy of Engineering, said: “UK universities produce some of the greatest innovations in the world, but getting them out of the lab and into the marketplace remains a huge challenge. Business-minded academics need investment and support from experienced industry practitioners to exploit their research, which could become the commercial success stories of tomorrow, and this is exactly what the Academy’s Enterprise Hub provides."
Keep up to date
Subscribe to news feeds